----------------------------------
                                  UNITED STATES                                    OMB APPROVAL
                       SECURITIES AND EXCHANGE COMMISSION               ----------------------------------
                             Washington, D.C. 20549                     OMB Number:             3235-0058
                                   FORM 12b-25                          Expires:           March 31, 2006
                          NOTIFICATION OF LATE FILING                   Estimated average burden hours per
                                                                        response.....................2.50
                                                                        ----------------------------------
                                                                                  SEC FILE NUMBER
                                                                        ----------------------------------
                                                                                   CUSIP NUMBER
                                                                        ----------------------------------





                                                                                                
(Check one): [X] Form 10-K    [ ] Form 20-F    [ ] Form 11-K    [ ] Form 10-Q    [ ] Form 10-D   [ ] Form N-SAR   [ ] Form N-CSR

             For Period Ended:   June 30, 2005
                               -------------------------------------------------------------------------------------------------

             [ ] Transition Report on Form 10-K
             [ ] Transition Report on Form 20-F
             [ ] Transition Report on Form 11-K
             [ ] Transition Report on Form 10-Q
             [ ] Transition Report on Form N-SAR
             For the Transition Period Ended:
                                             -----------------------------------------------------------------------------------


--------------------------------------------------------------------------------------------------------------------------------
                  Read Instructions (on back page) Before Preparing Form. Please Print or Type.
     Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
--------------------------------------------------------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

--------------------------------------------------------------------------------------------------------------------------------



PART I -- REGISTRANT INFORMATION

VISUALMED CLINICAL SOLUTIONS CORP.
--------------------------------------------------------------------------------
Full Name of Registrant

ANCONA MINING CORP.
--------------------------------------------------------------------------------
Former Name if Applicable

1035 LAURIER ST. WEST, SUITE 200
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

MONTREAL, QUEBEC CANADA H2V 2L1
--------------------------------------------------------------------------------
City, State and Zip Code


PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

        (a)    The reason described in reasonable detail in Part III of this
               form could not be eliminated without unreasonable effort or
               expense
        (b)    The subject annual report, semi-annual report, transition report
               on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or
[X]            portion thereof, will be filed on or before the fifteenth
               calendar day following the prescribed due date; or the subject
               quarterly report or transition report on Form 10-Q, or subject
               distribution report on Form 10-D, or portion thereof, will be
               filed on or before the fifth calendar day following the
               prescribed due date; and
        (c)    The accountant's statement or other exhibit required by Rule
               12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be
filed within the prescribed time period.

         VisualMED Clinical Solutions Corp. (the "Company") hereby requests an
extension of time to file its Annual Report on Form 10-KSB for the period ended
June 30, 2005. The Company was unable to file its Form 10-KSB by September 28,
2005 without unreasonable effort or expense because within the last fiscal year
ended June 30, 2005, the Company replaced its entire senior management and board
of directors. In addition, the Company retained new corporate counsel within the
last 30 days. The Company currently anticipates that the Form 10-KSB will be
filed by no later than the second calendar day following the date on which the
Form 10-KSB was due.


                  
SEC 1344 (03-05)     Persons who are to respond to the collection of information
                     contained in this form are not required to respond unless
                     the form displays a currently valid OMB control number.



Page 1 of 2



 




(Attach extra Sheets if Needed)
PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
notification


                                                     
                 JAYNE H. KIRBY                  514             274-1115
     ---------------------------------      --------------  -------------------
                    (Name)                   (Area Code)   (Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter period that the
     registrant was required to file such report(s) been filed? If answer is no,
     identify report(s).


                                                          [X] Yes      [ ]  No
     ---------------------------------------------------------------------------

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding period for the last fiscal year will be reflected by the
     earnings statements to be included in the subject report or portion
     thereof?

                                                          [ ] Yes      [X]  No
     ---------------------------------------------------------------------------

     If so, attach an explanation of the anticipated change, both narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

--------------------------------------------------------------------------------



                       VISUALMED CLINICAL SOLUTIONS CORP.
--------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date  SEPTEMBER 29, 2005                By  /s/ GERARD DAB
      ----------------------------          ------------------------------------


                                    ATTENTION

--------------------------------------------------------------------------------
   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------

                               GENERAL INSTRUCTIONS

1.   This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed original and four conformed copies of this form and amendments
     thereto must be completed and filed with the Securities and Exchange
     Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
     General Rules and Regulations under the Act. The information contained in
     or filed with the form will be made a matter of public record in the
     Commission files.

3.   A manually signed copy of the form and amendments thereto shall be filed
     with each national securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications must also be filed on Form 12b-25 but need
     not restate information that has been correctly furnished. The form shall
     be clearly identified as an amended notification.

5.   Electronic Filers: This form shall not be used by electronic filers unable
     to timely file a report solely due to electronic difficulties. Filers
     unable to submit reports within the time period prescribed due to
     difficulties in electronic filing should comply with either Rule 201 or
     Rule 202 of Regulation S-T ('SS'232.201 or 'SS'232.202 of this chapter) or
     apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
     S-T ('SS'232.13(b) of this chapter).



Page 2 of 2



                            STATEMENT OF DIFFERENCES
                            ------------------------

The section symbol shall be expressed as ................................ 'SS'